Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

PVTTF

Pivotal Therapeutics (CE) (PVTTF)

Pivotal Therapeutics Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:PVTTF
日付受信時刻ニュースソース見出しコード企業名
2014/05/0606 : 22MarketwiredCrossover Healthcare Fund Announces Ownership Interest in Pivotal Therapeutics Inc.USOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/10/0805 : 39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/10/0805 : 39OTC MarketsPivotal Therapeutics receives CDN $1.65 million in debt financing; Company closes equity portion of financing; over CDN $4.3 ...USOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/10/0221 : 54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/10/0221 : 54OTC MarketsPivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreementUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/09/1402 : 49OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/09/1402 : 46OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/09/0601 : 45OTC MarketsPIVOTAL THERAPEUTICS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS AND CORPORATE UPDATEUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/08/3104 : 24OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/08/3104 : 15OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/08/3104 : 11OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/08/3104 : 06OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3113 : 44OTC MarketsAnnual ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3113 : 41OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3113 : 33OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3113 : 31OTC MarketsProxy MaterialsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3113 : 29OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3012 : 51OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3012 : 49OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3012 : 38OTC MarketsInterim Financial ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3012 : 20OTC MarketsQuarterly ReportUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/3001 : 34OTC MarketsPivotal Therapeutics Announces First Quarter 2013 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/0723 : 55OTC MarketsPivotal Therapeutics VASCAZEN®-REVEAL trial meets primary and secondary endpoints - VASCAZEN® shows 121% correction o...USOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/0301 : 07OTC MarketsPivotal's Founder and Chairman Dr. George Jackowski receives Queen Elizabeth II Diamond Jubilee MedalUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/05/0107 : 08OTC MarketsPivotal Therapeutics VASCAZEN® - REVEAL Trial Top Line Results to be presented at American Heart Association's Arterioscl...USOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/04/3011 : 08OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/04/3011 : 07OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/04/3011 : 02OTC MarketsSupplemental InformationUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/04/3011 : 00OTC MarketsManagement Discussion and AnalysisUSOTC:PVTTFPivotal Therapeutics Inc (CE)
2013/04/3009 : 38OTC MarketsPivotal Therapeutics Announces 2012 Financial ResultsUSOTC:PVTTFPivotal Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:PVTTF